BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32506718)

  • 1. Prevalence of multidrug-resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta-analysis.
    Tengan FM; Figueiredo GM; Leite OH; Nunes AK; Manchiero C; Dantas BP; Magri MC; Barone AA; Bernardo WM
    Trop Med Int Health; 2020 Sep; 25(9):1065-1078. PubMed ID: 32506718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-extensively drug-resistant and extensively drug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis.
    Alarcon-Braga EA; Salazar-Valdivia FE; Estrada-Grossmann JM; Mendez-Guerra C; Pacheco-Barrios N; Al-Kassab-Córdova A
    Am J Infect Control; 2024 Mar; 52(3):349-357. PubMed ID: 38061402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
    Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
    BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
    Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
    J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
    Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
    BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
    Goyal V; Kadam V; Narang P; Singh V
    BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lönnroth K; Shaweno D; Gulliver A; Viney K
    J Infect; 2018 Nov; 77(5):357-367. PubMed ID: 30036607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Beijing and Haarlem genotypes among multidrug-resistant Mycobacterium tuberculosis in Iran: Systematic review and meta-analysis.
    Tarashi S; Fateh A; Jamnani FR; Siadat SD; Vaziri F
    Tuberculosis (Edinb); 2017 Dec; 107():31-37. PubMed ID: 29050769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
    Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
    BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-drug resistant tuberculosis burden and risk factors: an update.
    Marahatta SB
    Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.
    Kibret KT; Moges Y; Memiah P; Biadgilign S
    Infect Dis Poverty; 2017 Jan; 6(1):7. PubMed ID: 28093078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multidrug-resistant tuberculosis in prisons: Systematic review and meta-analysis.
    Moreira TR; Passos IBJ; Bueno JVL; Maffacciolli R; Colodette RM; Miguel PS
    Indian J Med Microbiol; 2022; 40(2):193-199. PubMed ID: 35120789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.